Meta Health Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Bernard Ng

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	2.4yrs
Eigendom CEO	2.4%
Management gemiddelde ambtstermijn	1.5yrs
Gemiddelde ambtstermijn bestuur	geen gegevens

Recente managementupdates

Recent updates

CEO

Bernard Ng (50 yo)

2.4yrs

Tenure

Dr. Kee Huat Ng, also known as Bernard, had been Executive Chairman until April 2024 and serves as its Executive Director since April 2024 and Group Chief Executive Officer of Meta Health Limited from June...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kee Huat Ng	Group CEO & Executive Director	2.4yrs	geen gegevens	2.38% SGD 171.5k
You Kong Cheah	Acting Head of Finance & Executive Officer	less than a year	geen gegevens	geen gegevens
Chee Wang Yip	Group Human Resources Manager	5.8yrs	geen gegevens	geen gegevens
Soo Fern Lee	Company Secretary	less than a year	geen gegevens	geen gegevens
Thanyarat Chanpet	Finance Manager of MCT Thailand Co.	no data	geen gegevens	geen gegevens
Hong Yu Ding	General Manager of MCE Technologies	no data	geen gegevens	geen gegevens

1.5yrs

Gemiddelde duur

Ervaren management: Het managementteam van 5DX wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.5 jaar), wat duidt op een nieuw team.

Meta Health Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

Meta Health Limited Announces the Appointment of Cheah You Kong as the Acting Head of Finance and as an Executive Officer, Effective May 1, 2024

Meta Health Limited, Annual General Meeting, Apr 29, 2024

High number of new directors

Meta Health Limited Announces Resignation of Tan Sze Leng as Chief Financial Officer, Effective from 17 May 2024

Meta Health Limited Announces the Cessation of Mr. Chua Kheng Choon as Senior Vice President of Engineering

High number of new and inexperienced directors

Recent updates

Meta Health Limited (Catalist:5DX) completed the acquisition of 55% stake in Jas Medical Screening Centre Pte Ltd from Lian Ah Lek for SGD 0.68 million.

New major risk - Revenue size

First half 2024 earnings released: EPS: S$0 (vs S$0.004 loss in 1H 2023)

New major risk - Share price stability

Meta Health Limited Announces the Appointment of Cheah You Kong as the Acting Head of Finance and as an Executive Officer, Effective May 1, 2024

Meta Health Limited, Annual General Meeting, Apr 29, 2024

High number of new directors

Meta Health Limited Announces Resignation of Tan Sze Leng as Chief Financial Officer, Effective from 17 May 2024

New major risk - Negative shareholders equity

Full year 2023 earnings released: S$0.004 loss per share (vs S$0.016 loss in FY 2022)

New minor risk - Financial data availability

Meta Health Limited Announces the Cessation of Mr. Chua Kheng Choon as Senior Vice President of Engineering

High number of new and inexperienced directors

New major risk - Shareholder dilution

High number of new and inexperienced directors

Meta Health Limited Appoints Lim Qing Ru as Independent Non-Executive Director, Member of the Audit Committee, the Nominating Committee and the Remuneration Committee, Effective from 1 November 2023

New major risk - Share price stability

New major risk - Revenue and earnings growth

First half 2023 earnings released: S$0.004 loss per share (vs S$0.005 loss in 1H 2022)

New major risk - Share price stability

Full year 2022 earnings released: S$0.013 loss per share (vs S$0.018 profit in FY 2021)

Meta Health Limited to Report Fiscal Year 2022 Results on Mar 01, 2023

Meta Health Limited Announces Resignation of Mak Peng Leong Philip as Joint Company Secretary, Effect from 12 December 2022

Executive Chairman & Group CEO recently bought S$59k worth of stock

Meta Health Limited Appoints Tan Sze Leng as Chief Financial Officer, Effective from 21 September 2022

Executive Chairman & Group CEO recently bought S$59k worth of stock

First half 2022 earnings released

Meta Health Limited Provides Financial Guidance for the First Half Year Ended June 30, 2022

High number of new and inexperienced directors

Meta Health Limited Announces Appointment of Law Ren Kai Kenneth as Independent Non-Executive Director, Chairman of the Audit Committee, and A Member of the Nominating Committee and the Remuneration Committee

Meta Health Limited Announces Resignation of Mak Peng Leong Philip as Joint Company Secretary, Effective 12 December 2022

Meta Health Limited Announces Resignation Leow Siew Yon, Cynthia as Independent Non-Executive Director, Chairman of the Nominating Committee, and a Member of the Audit Committee and the Remuneration Committee

Meta Health Limited Announces Management Changes

Full year 2021 earnings released: EPS: S$0.018 (vs S$0.005 loss in FY 2020)

Meta Health Limited, Annual General Meeting, Apr 28, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Now 23% undervalued after recent price drop

Metal Precision Services Pte Ltd. completed the acquisition of 85.07% stake in Gainhealth Pte. Ltd. from Jagannathan Padmaja Sakthi, Fu Yijie and Yeo Kang Nian.

Metal Component Engineering Limited (Catalist:5DX) agreed to acquire Gainhealth Pte. Ltd. from Jagannathan Padmaja Sakthi, Fu Yijie and Yeo Kang Nian for SGD 11.1 million.

Metal Component Engineering Considers Potential Acquisition

Independent Non-Executive Director has left the company

Full year 2020 earnings released

Metal Component Engineering Limited Announces Board Changes, Effective January 1, 2021

Metal Component Engineering Limited Provides Group Earnings Guidance for the Half Year Ended 30 June 2020

Metal Component Engineering Limited to Report First Half, 2020 Results on Aug 14, 2020

CEO

Tenure

Leiderschapsteam

Gemiddelde duur